MedTrace Logo

Sucrosomial Vs Intravenous Iron for Preoperative Anemia

NCT07287371 · Status: NOT_YET_RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2025-12-17

No results posted yet for this study

Summary

50 patients with anemia scheduled for heart surgery or procedures will be randomized to receive either oral sucrosomial iron or standard-of-care intravenous iron before surgery to see if the oral iron is as effective as intravenous iron in increasing the red blood cell count.

Conditions

Interventions

DRUG

Treatment with oral sucrosomial iron

blood draw on the day of surgery to check hemoglobin and red blood cell count and iron studies

DRUG

Treatment with intravenous iron

2 infusions of intravenous iron (ferumoxytol)

Sponsors & Collaborators

  • Pharmanutra S.p.a.

    collaborator INDUSTRY

  • University of Rochester

    lead OTHER

Principal Investigators

  • Michael P Eaton, MD · University of Rochester

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-12-31
Primary Completion
2027-06-30
Completion
2027-06-30
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07287371 on ClinicalTrials.gov